Potential of aqueous two‐phase systems for the separation of levodopa from similar biomolecules
BACKGROUND Levodopa is a precursor of several neurotransmitters, such as dopamine, and is used in the treatment of Parkinson's disease. In this work, an alternative strategy was studied to separate levodopa from similar biomolecules using aqueous two‐phase systems (ATPS). RESULTS Ternary ATPS c...
Saved in:
Published in: | Journal of chemical technology and biotechnology (1986) Vol. 93; no. 7; pp. 1940 - 1947 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chichester, UK
John Wiley & Sons, Ltd
01-07-2018
Wiley Subscription Services, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BACKGROUND
Levodopa is a precursor of several neurotransmitters, such as dopamine, and is used in the treatment of Parkinson's disease. In this work, an alternative strategy was studied to separate levodopa from similar biomolecules using aqueous two‐phase systems (ATPS).
RESULTS
Ternary ATPS composed of polyethylene glycol (PEG) 400 or ionic liquids (ILs), citrate buffer (K3C6H5O7/C6H8O7) at pH 7.0 and water, and quaternary ATPS composed of PEG 400, K3C6H5O7/C6H8O7 at pH 7.0, water and the same ILs at 5 wt%, were studied. The respective liquid–liquid phase diagrams were determined at 298 K to appraise the mixture compositions required to form two‐phase systems, followed by studies of the partition of levodopa and structurally similar biomolecules (dopamine, L‐phenylalanine, and L‐tyrosine). Their partition coefficients and extraction efficiencies have been determined, and the selectivity of the ATPS to separate levodopa from the remaining biomolecules evaluated.
CONCLUSION
The results obtained indicated that PEG‐based ATPS were the most effective to separate levodopa from L‐phenylalanine while the separation from the other biomolecules was better using IL‐based ATPS, in particular those based on [P4444]Cl and [N4444]Cl, with extraction efficiencies of levodopa to the salt‐rich phase ranging between 62.7 and 74.0%, and of the remaining biomolecules to polymer/IL‐rich phase up to 91.5%. © 2017 Society of Chemical Industry |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0268-2575 1097-4660 |
DOI: | 10.1002/jctb.5553 |